FDA should improve incentives to lower drug costs, says Dyadic CEO
The FDA needs to expedite the approval process to provide incentives for the development of more affordable drugs, says Dyadic CEO.
Archives for July 2, 2019
Fujifilm plots third cell culture facility in Netherlands
Fujifilm announces plans to open its third manufacturing facility for cell culture media, joining existing facilities in the US and Japan.
FDA approves Pfizer’s oncology mAb biosimilar Zirabev
Avastin biosimilar from Pfizer receives approval from the FDA for the treatment of five forms of cancers, increasing market competition for the originator drug.
Amicus picks Brammer for preclinical, clinical gene therapy work
Rare disease drug developer to work with Brammer Bio – which Thermo Fisher acquired in March – on gene therapy programs against Batten disease.
Catalent bolsters Paragon through Novavax deal
Aiming to boost the gene therapy development and manufacturing capabilities of Paragon, which Catalent acquired in April, the CDMO has agreed to acquire all of the gene therapy-related assets from Novavax, a late-stage vaccine developer.